Sukigara M, Taguchi Y, Yamazaki T, Koga K, Miyamae T, Omoto R
Nihon Geka Gakkai Zasshi. 1984 Dec;85(12):1523-7.
The purpose of this study is to know the systemic distribution of sclerosant injected into esophageal varices. Sclerotherapy for esophageal varices was performed for 14 times in 11 patients. The patients were divided into two groups according to the content of sclerosant. Seven patients received a total of 9 intravariceal injections (IVI) with 7 to 30ml of 5% ethanolamine oleate (EO) which contained meglumine diatrizoate (Angiographin) and four patients received a total of 5 IVI with 10 to 20ml of 4.5% EO which contained a 10% volume of 99mTcO-4 solution (EO-99mTc). Distribution of injected materials was observed by X-ray fluoroscopy in the former group and by a scintillation camera in the latter. In both methods most of the sclerosant disappeared from the injected site within five minutes leaving a trace in the varices. Then, the sclerosant was disseminated throughout the body via portal vein. When more than 20ml of sclerosant was injected, some flowed into the azygos vin through the periesophageal vin. After IVI the varices showed atrophic changes, though the sclerosant did not stay in the varices.
本研究的目的是了解注入食管静脉曲张的硬化剂的全身分布情况。对11例患者进行了14次食管静脉曲张硬化治疗。根据硬化剂的成分将患者分为两组。7例患者共接受9次曲张静脉内注射(IVI),注射含泛影葡胺(安吉奥格拉芬)的5%油酸乙醇胺(EO)7至30毫升,4例患者共接受5次IVI,注射含10%体积的99mTcO-4溶液的4.5% EO(EO-99mTc)10至20毫升。前一组通过X线透视观察注射物质的分布,后一组通过闪烁照相机观察。两种方法均显示,大部分硬化剂在5分钟内从注射部位消失,在静脉曲张内留下痕迹。然后,硬化剂通过门静脉在全身扩散。当注入超过20毫升硬化剂时,一些硬化剂通过食管周围静脉流入奇静脉。IVI后,尽管硬化剂未留在静脉曲张内,但静脉曲张出现萎缩性改变。